Company: CYTK
Filing Date: 2025-03-31
Form Type: PRE 14A
Source: 0001140361-25-011212
Chunk: 88

Company: CYTOKINETICS INC
Filing Date: 2025-03-31
Form: PRE 14A
Chunk 88
---
 As a result, as the SEC explained when it adopted the Rule, in considering the pay-ratio disclosure, stockholders should keep in mind that the Rule was not designed to facilitate comparisons of pay ratios among different companies, even companies within the same industry, but rather to allow stockholders to better understand and assess each particular company’s compensation practices and pay-ratio disclosures. In determining the median employee, we prepared a listing of all employees (excluding Mr. Blum) using a measurement date of December 31, 2024, annualized the salaries for those employees that were not employed for all of 2024 and identified the employee at the median of the listing of annualized salaries (the “Median Employee”). We calculated the Median Employee Compensation for 2024 for the Median Employee on the same basis as the total compensation of Mr. Blum in the Executive Summary Compensation Table.

| Cytokinetics, Inc.|2025 Proxy Statement |     | 61 |

TABLE OF CONTENTS

Pay Versus Performance As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive compensation actually paid and the Company's financial performance. As described in “Financial Performance Measures” below, we do not have a Company Selected Financial Measure as described in Item 402(v)(2)(vi) of Regulation S-K to link compensation actually paid (“CAP”) to our performance. Required Tabular Disclosure of Compensation Actually Paid Versus Performance The following table discloses information on CAP to our principal executive officer and (on average) to our other named executive officers during the specified years alongside total shareholder return (“TSR”) and net income metrics. Pay versus Performance Table

| Year        |     |      Summary 
 Compensation 
  Table Total 
   for PEO(1) |     |  Compensation 
 Actually Paid 
     to PEO(2) |     |      Average 
      Summary 
 Compensation 
  Table Total 
  for non-PEO 
      NEOs(3) |     |       Average 
  Compensation 
 Actually Paid 
    to non-PEO 
       NEOs(4) |     | Value Of Initial Fixed $100 
        Investment Based On: |     |      |     |    Net Loss 
 (thousands) |     | Company    
 Selected   
 Measure(7) |
| Total       
 Shareholder 
 Return(5)   |     |   Peer Group